or Try an Advanced Search...

    Kidney Disease Stocks List

    Symbol Grade Name % Change
    OPK D OPKO Health Inc. -1.52
    XBIO F Xenetic Biosciences, Inc. -1.33
    ICU F SeaStar Medical Holding Corporation -1.05
    FGEN F FibroGen, Inc -0.83
    DMAC C DiaMedica Therapeutics Inc. -0.65
    PIRS F Pieris Pharmaceuticals, Inc. 0.00
    RMTI C Rockwell Medical, Inc. 0.00
    LGND C Ligand Pharmaceuticals Incorporated 0.43
    SNY C Sanofi 1.09
    AZN A Astrazeneca PLC 2.68
    View As Page of Charts
    Related Industries: Biotechnology Data Storage Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
    Related Stock Lists: Biopharmaceutical Chronic Kidney Disease Renal Disease Anemia Biotechnology End Stage Renal Disease Life Sciences Medicine Stage Renal Disease Cancer Clinical Development Diabetic Nephropathy Dialysis Disease Dysfunction Gastrointestinal Heart Failure Hypoxia Inducible Factors Inflammation Inflammation Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Kidney Disease stocks.

    Symbol Grade Name Weight
    PPH B Market Vectors Pharmaceutical ETF 10.43
    IBBQ B Invesco Nasdaq Biotechnology ETF 6.35
    MEDX D Horizon Kinetics Medical ETF 5.71
    SURE B AdvisorShares Insider Advantage ETF 5.3
    BIB C ProShares Ultra Nasdaq Biotechnology 4.37
    View all Kidney Disease ETFs...
    Compare ETFs
    Compare IBBQ to MEDX Compare MEDX to BIB Compare SURE to BIB

        Kidney Disease Stocks Recent News

        Date Stock Title
        May 21 AZN AstraZeneca’s $80B sales plan leans on cancer drug expansion
        May 21 AZN AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
        May 21 AZN European Equities Close Lower in Tuesday Trading; AstraZeneca Targets $80 Billion in Revenue by 2030
        May 21 SNY ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
        May 21 AZN AstraZeneca sets sights on $80B in revenue by 2030
        May 21 AZN AstraZeneca projects $80B in revenue by 2030
        May 21 AZN AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion
        May 21 SNY Sanofi teams up with Formation Bio, OpenAI on AI-driven drug development
        May 21 AZN Trending tickers: Trump Media, Palo Alto, AstraZeneca and Kingfisher
        May 21 AZN AstraZeneca to establish $1.5bn ADC production site in Singapore
        May 21 AZN Lowe's, Macy's, Xpeng rise premarket; Palo Alto, Zoom fall
        May 21 AZN AstraZeneca Targets $80 Billion Revenue by 2030 Through Pipeline Expansion
        May 21 AZN AstraZeneca shares rise as pharma group unveils 2030 revenue target
        May 21 AZN AstraZeneca aims for $80 billion in total revenue by 2030
        May 21 AZN AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
        May 21 SNY Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
        May 21 AZN European stocks fall on Fed rate concerns; AstraZeneca lifts revenue target
        May 20 SNY Sanofi: Information concerning the total number of voting rights and shares - April 2024
        May 20 AZN Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
        May 20 AZN Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population
        Related Industries: Biotechnology Data Storage Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
        Related Stock Lists: Chronic Kidney Disease Renal Disease Biopharmaceutical End Stage Renal Disease Phosphates Stage Renal Disease Biotechnology Cancer Dialysis Health Sciences Life Sciences Pharmacy Acid Alzheimer's Disease Asthma Chronic Obstructive Pulmonary Disease Clopidogrel Gastrointestinal Heart Failure Hemodialysis
        Kidney Disease

        Kidney disease is a condition in which the kidneys are damaged and unable to filter waste and toxins from the blood. This can lead to a buildup of waste and toxins in the body, which can cause a variety of symptoms, including fatigue, nausea, loss of appetite, and swelling in the hands and feet. In severe cases, kidney disease can lead to kidney failure, which requires dialysis or a kidney transplant.

        Browse All Tags